CAR-T cell therapy granted RMAT for relapsed/refractory multiple myeloma
An investigational CT053 CAR-T cell therapy for RRMM has been given Regenerative Medicine Advanced Therapy designation.
List view / Grid view
An investigational CT053 CAR-T cell therapy for RRMM has been given Regenerative Medicine Advanced Therapy designation.
Allergen is to reportedly settle a class-action lawsuit which alleges that it worked to delay generic competition for Alzheimer’s disease therapy Namenda.
Due to possible contamination from a foreign substance, Mylan Pharmaceuticals is voluntarily recalling one batch of its Alprazolam tablets.
Researchers have found that 33 percent of companies in the life sciences sector experienced an information leak within the last year.
A study has shown that macroscopic hollow spheres can be distorted to deflate and potentially release their contents, which could be imitated by microscopic drug delivery techniques.
XospataTM (gilteritinib) has been approved as a monotherapy for patients with relapsed or refractory acute myeloid leukaemia with a FLT3 mutation.
A new liquid formulation of hydroxycarbamide to treat sickle cell disease will “enable doctors to personalise doses in children".
The UK healthcare agency has issued an alert for Perrigo ranitidine products, recalling and quarantining certain batches.
A new report has predicted that gene therapy development will pick up pace but a high price point continues to pose a challenge.
A study has found that 25 percent of drugs with one or more new molecular entities approved by the FDA come from publicly funded research.
The FDA has announced its support of a drug manufacturer rating system that would allow purchasers to identify which have the most reliable supply, in an effort to reduce shortages.
A new agreement will allow eligible cystic fibrosis patients in England to have access to CFTR modulators to treat the underlying cause of their disease.
Encapsulation technology, a simple and efficient technique to coat liquid medication in milliseconds, could improve drug delivery.
The FDA has released an additional NDMA testing method and has alerted the public to multiple voluntary recalls of ranitidine.
Speaker Pelosi’s bill to lower medicine prices in the US has passed through a House committee, ready for a full vote.